RU96122652A - RANITIDINE TABLET COATED WITH HYDROXYPROPYLMETHYL CELLULOSE AND METHOD FOR APPLYING SUCH COATING - Google Patents

RANITIDINE TABLET COATED WITH HYDROXYPROPYLMETHYL CELLULOSE AND METHOD FOR APPLYING SUCH COATING

Info

Publication number
RU96122652A
RU96122652A RU96122652/14A RU96122652A RU96122652A RU 96122652 A RU96122652 A RU 96122652A RU 96122652/14 A RU96122652/14 A RU 96122652/14A RU 96122652 A RU96122652 A RU 96122652A RU 96122652 A RU96122652 A RU 96122652A
Authority
RU
Russia
Prior art keywords
ranitidine
coating
weight
solution
cellulose
Prior art date
Application number
RU96122652/14A
Other languages
Russian (ru)
Other versions
RU2117476C1 (en
Inventor
Больс Педерсен Серен
Эрик Гебхардт-Хансен Кнуд
Канн Хелле
Original Assignee
А/С Геа Фармасьютиск Фабрик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK046894A external-priority patent/DK171127B1/en
Application filed by А/С Геа Фармасьютиск Фабрик filed Critical А/С Геа Фармасьютиск Фабрик
Application granted granted Critical
Publication of RU2117476C1 publication Critical patent/RU2117476C1/en
Publication of RU96122652A publication Critical patent/RU96122652A/en

Links

Claims (6)

1. Таблетка ранитидина, содержащая по крайней мере 30 вес.% гидрохлорида ранитидина и имеющая покрытие, содержащее гидроксипропилметилцеллюлозу, отличающаяся тем, что упомянутое покрытие включает гидроксипропилметилцеллюлозу в соотношении от 10:1 до 1:2.1. A ranitidine tablet containing at least 30 wt.% Ranitidine hydrochloride and having a coating containing hydroxypropyl methyl cellulose, characterized in that said coating comprises hydroxypropyl methyl cellulose in a ratio of 10: 1 to 1: 2. 2. Таблетка ранитидина по п.1, отличающаяся тем, что весовое отношение гидроксиметилцеллюлозы к этилцеллюлозе составляет от 4:1 до 1:1. 2. The ranitidine tablet according to claim 1, characterized in that the weight ratio of hydroxymethyl cellulose to ethyl cellulose is from 4: 1 to 1: 1. 3. Способ получения нужного покрытия при производстве таблеток ранитидина по п.1 или 2, отличающийся тем, что готовят раствор, содержащий от 2,5 до 9 вес.% гидроксипропилметилцеллюлозы и от 1,5 до 6 вес.% этилцеллюлозы и не обязательно, в растворенной и/или суспендированной форме, обычные пластификаторы, красители и пигменты, а также другие традиционные адъюванты, в водном спирте, содержащем 72,5-82,5 вес. % спирта, выбранного из метанола, этанола, н- и изопропанола, и раствор наносят распылением на таблетки, содержащие гидрохлорид ранитидина, перемещая их в потоке сухого воздуха, имеющего температуру, при которой водный спирт испаряется. 3. The method of obtaining the desired coating in the manufacture of ranitidine tablets according to claim 1 or 2, characterized in that a solution is prepared containing from 2.5 to 9 wt.% Hydroxypropyl methylcellulose and from 1.5 to 6 wt.% Ethyl cellulose and not necessarily, in dissolved and / or suspended form, conventional plasticizers, dyes and pigments, as well as other traditional adjuvants, in aqueous alcohol containing 72.5-82.5 weight. % alcohol selected from methanol, ethanol, n- and isopropanol, and the solution is sprayed onto tablets containing ranitidine hydrochloride, moving them in a stream of dry air at a temperature at which the aqueous alcohol evaporates. 4. Способ по п.3, отличающийся тем, что готовят раствор, имеющий содержание гидроксипропилметилцеллюлозы плюс этилцеллюлоза, до 7-15 вес.% в водном приблизительно 78% (по весу) этиловом спирте. 4. The method according to claim 3, characterized in that a solution is prepared having a hydroxypropyl methyl cellulose plus ethyl cellulose content of up to 7-15% by weight in aqueous 78% (by weight) ethyl alcohol. 5. Способ по п.3 или 4, отличающийся тем, что в раствор дополнительно включают поверхностно-активное вещество. 5. The method according to claim 3 or 4, characterized in that the solution further includes a surfactant. 6. Способ по п.5, отличающийся тем, что поверхностно-активное вещество представляет собой Полисорбат 80. 6. The method according to claim 5, characterized in that the surfactant is Polysorbate 80.
RU96122652A 1994-04-22 1995-04-19 Ranitidine tablet covered by hydroxypropylmethylcellulose and a method of cover applying RU2117476C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK046894A DK171127B1 (en) 1994-04-22 1994-04-22 The ranitidine tablet with a hydroxypropylmethylcellulose-containing coating as well as a method for providing this coating
DK0468/94 1994-04-22

Publications (2)

Publication Number Publication Date
RU2117476C1 RU2117476C1 (en) 1998-08-20
RU96122652A true RU96122652A (en) 1999-01-27

Family

ID=8093891

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96122652A RU2117476C1 (en) 1994-04-22 1995-04-19 Ranitidine tablet covered by hydroxypropylmethylcellulose and a method of cover applying

Country Status (26)

Country Link
US (1) US5741507A (en)
EP (1) EP0794768A1 (en)
JP (1) JPH09512023A (en)
KR (1) KR970702031A (en)
CN (1) CN1146148A (en)
AU (1) AU690680B2 (en)
BG (1) BG100992A (en)
BR (1) BR9507486A (en)
CA (1) CA2187323A1 (en)
CZ (1) CZ283645B6 (en)
DE (1) DE794768T1 (en)
DK (1) DK171127B1 (en)
EE (1) EE03248B1 (en)
ES (1) ES2106696T1 (en)
FI (1) FI964238A0 (en)
GR (1) GR970300040T1 (en)
HU (1) HUT75962A (en)
IS (1) IS4375A (en)
LV (1) LV11591B (en)
MD (1) MD984B1 (en)
NO (1) NO964198D0 (en)
NZ (1) NZ284792A (en)
PL (1) PL316965A1 (en)
RU (1) RU2117476C1 (en)
SK (1) SK134896A3 (en)
WO (1) WO1995028918A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW464502B (en) * 1996-03-12 2001-11-21 Shiseido Co Ltd W/O type emulsified composition and the method of making the same, and W/O type emulsified cosmetic
US6306164B1 (en) 1997-09-05 2001-10-23 C. R. Bard, Inc. Short body endoprosthesis
IT1311915B1 (en) * 1999-04-12 2002-03-20 Pharmexcel S R L RANITIDINE HYDROCHLORIDE ANHYDROUS TABLET WITH DOUBLE-LAYER COATING AND ITS COMPOSITION.
SE9903879D0 (en) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
KR100459770B1 (en) * 2002-01-29 2004-12-04 전자부품연구원 Method for consolidating silica fine particles deposited on a wafer
US20050152932A1 (en) * 2003-06-12 2005-07-14 Valery Normand Non-crystalline perfume or flavor delivery system
US7641362B2 (en) * 2007-04-30 2010-01-05 Hewlett-Packard Development Company, L.P. Electronic device lighting system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine

Similar Documents

Publication Publication Date Title
RU95104236A (en) PHARMACEUTICAL COMPOSITION
ES2165833T1 (en) ENTERIC COVERED PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCEDURE.
SE8702907D0 (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME
AR048457A2 (en) PROCESS FOR FORMING A PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
RU2008106220A (en) GASTRORETENTIVE COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE
RU96122652A (en) RANITIDINE TABLET COATED WITH HYDROXYPROPYLMETHYL CELLULOSE AND METHOD FOR APPLYING SUCH COATING
RU2008130873A (en) COMBINED COMPOSITION, INCLUDING AMLODIPINE CAMSILATE AND SIMVASTATIN AND METHOD FOR PREPARING IT
RU96120199A (en) IMMUNOSUPRESSIVE COMPOSITION CONTAINING CYCLOSPORIN AND METHOD FOR PRODUCING IT
KR880004805A (en) Spray dried acetaminophen
KR880004803A (en) Spray dried acetaminophen
CO5150199A1 (en) PROCEDURE FOR THE PREPARATION OF A DELAYED RELEASE COMPOSITION AND COMPOSITION PREPARED BY THE PROCEDURE
SE8300577L (en) COVERAGE PROVIDING REGULATED DELIVERY OF ACTIVE INGREDIENTS FROM BIOLOGICALLY ACTIVE MIXTURES, IN PARTICULAR PHARMACEUTICAL PREPARATIONS, AS WELL AS TO MAKE BIOLOGICALLY ACTIVE MIXTURES WITH REGULATED ....
RU98104946A (en) COMPOSITIONS OF RAPAMICIN FOR Oral Administration
KR970702031A (en) A RANITIDINE TABLET HAVING A HYDROXYPROPYLMETHYLCELLULOSE CONTAINING COATING AND A METHOD FOR PRODUCING SAID COATING
RU2004118495A (en) OBTAINING A COMPOSITION CONTAINING UNSTABLE AS TO AN ACID PHYSIOLOGICALLY ACTIVE COMPOUND AND METHOD FOR PRODUCING IT
ES2090490T3 (en) SUPPLIES OF PROLONGED RELEASE AND A PROCEDURE FOR ITS PREPARATION.
HRP20020344B1 (en) Method for the preparation of citalopram
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
DE3877621D1 (en) DRY ORAL THEOPHYLLINE PREPARATION WITH DELAYED RELEASE.
KR840004121A (en) Stabilization Method of Azrene Derivatives
ES2122387T3 (en) PROCEDURE FOR THE PREPARATION OF FORM 1 OF RANITIDINE CHLORHYDRATE.
RU2020101925A (en) Oral Betahistine-Based Solid Compositions with Non-Pulsed Sustained Release
KR940006586A (en) Oral preparation of omeprazole by multilayer alkali coating and preparation method thereof
RU2003130115A (en) STABLE PHARMACEUTICAL SUSPENSION OF AZITHROMYCIN AND METHOD OF ITS PRODUCTION
RU99125610A (en) SOLID PHARMACEUTICAL PREPARATIONS CONTAINING A PHYSICAL MIXTURE OF SULPHOLKYL ETHER OF CYCLODEXTRINE AND THERAPEUTIC AGENT